Position in BVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,181,261
+$139,922 QoQ
Shares Held
336,998
+1.2% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 155 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $534,029,320 across 47 Medical Devices names. BVS ranks #27 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,202,710 | $109,133,905 | |
| 2 | PODD |
Insulet Corp
|
446,382 | $67,961,659 | |
| 3 | SYK |
Stryker Corp
|
145,506 | $45,811,109 | |
| 4 | BSX |
Boston Scientific Corp
|
986,764 | $42,115,087 | |
| 5 | EW |
Edwards Lifesciences Corp
|
445,266 | $40,278,762 | |
| 6 | INMD |
InMode Ltd.
|
2,583,988 | $37,777,904 | |
| 7 | TCMD |
Tactile Systems Technology Inc
|
903,553 | $26,907,808 | |
| 8 | MDT |
Medtronic plc
|
173,980 | $13,610,455 |
All Filings in BVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,181,261 | 336,998 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,041,339 | 333,115 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $419,169 | 56,340 | Shares | Defined | 2026-02-10 | |
| 2025-06-30 | $891,237 | 134,628 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,185,538 | 129,567 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $1,483,503 | 141,286 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,224,313 | 186,135 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $160,747 | 27,956 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $28,896 | 5,557 | Shares | Defined | 2024-05-10 | |
| 2021-06-30 | $219,313 | 12,461 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||